The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
- PMID: 34884942
- PMCID: PMC8658661
- DOI: 10.3390/ijms222313135
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Abstract
Liver cancer is the third leading cause of cancer death worldwide. Representing such a dramatic impact on our lives, liver cancer is a significant public health concern. Sustainable and reliable methods for preventing and treating liver cancer require fundamental research on its molecular mechanisms. Cell lines are treated as in vitro equivalents of tumor tissues, making them a must-have for basic research on the nature of cancer. According to recent discoveries, certified cell lines retain most genetic properties of the original tumor and mimic its microenvironment. On the other hand, modern technologies allowing the deepest level of detail in omics landscapes have shown significant differences even between samples of the same cell line due to cross- and mycoplasma infection. This and other observations suggest that, in some cases, cell cultures are not suitable as cancer models, with limited predictive value for the effectiveness of new treatments. HepG2 is a popular hepatic cell line. It is used in a wide range of studies, from the oncogenesis to the cytotoxicity of substances on the liver. In this regard, we set out to collect up-to-date information on the HepG2 cell line to assess whether the level of heterogeneity of the cell line allows in vitro biomedical studies as a model with guaranteed production and quality.
Keywords: HepG2 cell line; hepatoblastoma; hepatocellular carcinoma; hepatocytes; mutations.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.BMC Cancer. 2012 Sep 10;12:402. doi: 10.1186/1471-2407-12-402. BMC Cancer. 2012. PMID: 22963400 Free PMC article.
-
NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.Clin Hemorheol Microcirc. 2019;73(1):249-260. doi: 10.3233/CH-199226. Clin Hemorheol Microcirc. 2019. PMID: 31561354 Free PMC article.
-
Cellular responses of normal (HL-7702) and cancerous (HepG2) hepatic cells to dust extract exposure.Chemosphere. 2018 Feb;193:1189-1197. doi: 10.1016/j.chemosphere.2017.11.123. Epub 2017 Dec 1. Chemosphere. 2018. PMID: 29874748
-
Effects of miR-489 targeting on SOX4 gene on proliferation and apoptosis of human hepatocellular carcinoma cells.Afr Health Sci. 2020 Sep;20(3):1292-1298. doi: 10.4314/ahs.v20i3.34. Afr Health Sci. 2020. PMID: 33402977 Free PMC article.
-
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30. Gastroenterology. 2017. PMID: 28043904 Review.
Cited by
-
AM-DMF-SCP: Integrated Single-Cell Proteomics Analysis on an Active Matrix Digital Microfluidic Chip.JACS Au. 2024 Mar 26;4(5):1811-1823. doi: 10.1021/jacsau.4c00027. eCollection 2024 May 27. JACS Au. 2024. PMID: 38818059 Free PMC article.
-
Hepatotoxicity assessment of innovative nutritional supplements based on olive-oil formulations enriched with natural antioxidants.Front Nutr. 2024 May 15;11:1388492. doi: 10.3389/fnut.2024.1388492. eCollection 2024. Front Nutr. 2024. PMID: 38812942 Free PMC article.
-
The hepatoprotective effect of 4-phenyltetrahydroquinolines on carbon tetrachloride induced hepatotoxicity in rats through autophagy inhibition.Biol Res. 2024 May 27;57(1):32. doi: 10.1186/s40659-024-00510-4. Biol Res. 2024. PMID: 38797855 Free PMC article.
-
Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins.J Pharmacokinet Pharmacodyn. 2024 May 1. doi: 10.1007/s10928-024-09922-x. Online ahead of print. J Pharmacokinet Pharmacodyn. 2024. PMID: 38691205
-
Antiproliferative Activity of N-Acylhydrazone Derivative on Hepatocellular Carcinoma Cells Involves Transcriptional Regulation of Genes Required for G2/M Transition.Biomedicines. 2024 Apr 18;12(4):892. doi: 10.3390/biomedicines12040892. Biomedicines. 2024. PMID: 38672246 Free PMC article.
References
-
- Khanal T., Kim H.G., Hwang Y.P., Kong M.J., Kang M.J., Yeo H.K., Kim D.H., Jeong T.C., Jeong H.G. Role of Metabolism by the Human Intestinal Microflora in Arbutin-Induced Cytotoxicity in HepG2 Cell Cultures. Biochem. Biophys. Res. Commun. 2011;413:318–324. doi: 10.1016/j.bbrc.2011.08.094. - DOI - PubMed
-
- Steinbrecht S., König R., Schmidtke K.-U., Herzog N., Scheibner K., Krüger-Genge A., Jung F., Kammerer S., Küpper J.-H. Metabolic Activity Testing Can Underestimate Acute Drug Cytotoxicity as Revealed by HepG2 Cell Clones Overexpressing Cytochrome P450 2C19 and 3A4. Toxicology. 2019;412:37–47. doi: 10.1016/j.tox.2018.11.008. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical